A new trading day began on Monday, with Spyre Therapeutics Inc (NASDAQ: SYRE) stock price up 7.15% from the previous day of trading, before settling in for the closing price of $30.61. SYRE’s price has ranged from $10.91 to $35.31 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 44.65% over the last five years. Meanwhile, its annual earnings per share averaged 35.16%. With a float of $67.53 million, this company’s outstanding shares have now reached $77.59 million.
Spyre Therapeutics Inc (SYRE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Spyre Therapeutics Inc is 12.99%, while institutional ownership is 77.26%. The most recent insider transaction that took place on Jan 02 ’26, was worth 460,134. In this transaction Chief Executive Officer of this company sold 15,000 shares at a rate of $30.68, taking the stock ownership to the 671,907 shares. Before that another transaction happened on Dec 01 ’25, when Company’s Chief Executive Officer sold 15,000 for $29.02, making the entire transaction worth $435,356. This insider now owns 686,907 shares in total.
Spyre Therapeutics Inc (SYRE) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.81 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 35.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.65% during the next five years compared to 44.65% growth over the previous five years of trading.
Spyre Therapeutics Inc (NASDAQ: SYRE) Trading Performance Indicators
Here are Spyre Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.18, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -2.87 in one year’s time.
